2-Amino-4-(4-chlorophenyl)thiazole - CAS 2103-99-3
Catalog: |
BB016560 |
Product Name: |
2-Amino-4-(4-chlorophenyl)thiazole |
CAS: |
2103-99-3 |
Synonyms: |
4-(4-chlorophenyl)-1,3-thiazol-2-amine |
IUPAC Name: | 4-(4-chlorophenyl)-1,3-thiazol-2-amine |
Description: | 2-Amino-4-(4-chlorophenyl)thiazole (CAS# 2103-99-3) is used in biological studies to evaluate the structure activity relationship of tricyclic aminothiazoles as angiogensis inhibitors. |
Molecular Weight: | 210.68 |
Molecular Formula: | C9H7ClN2S |
Canonical SMILES: | C1=CC(=CC=C1C2=CSC(=N2)N)Cl |
InChI: | InChI=1S/C9H7ClN2S/c10-7-3-1-6(2-4-7)8-5-13-9(11)12-8/h1-5H,(H2,11,12) |
InChI Key: | DWGWNNCHJPKZNC-UHFFFAOYSA-N |
Boiling Point: | 389.8 °C at 760 mmHg |
Melting Point: | 169-171 °C |
Purity: | 95 % |
Density: | 1.389 g/cm3 |
Appearance: | White to light yellow crystal powde |
MDL: | MFCD00047058 |
LogP: | 3.62690 |
GHS Hazard Statement: | H301 (96.99%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021012018-A1 | Inhibitor compounds | 20190724 |
EP-3407912-A1 | Methods for enhancing the potency of the immune checkpoint inhibitors | 20160128 |
US-2019031757-A1 | Methods for enhancing the potency of the immune checkpoint inhibitors | 20160128 |
WO-2017129769-A1 | Methods for enhancing the potency of the immune checkpoint inhibitors | 20160128 |
US-10822415-B2 | Methods for enhancing the potency of the immune checkpoint inhibitors | 20160128 |
PMID | Publication Date | Title | Journal |
22091133 | 20110801 | 4-(4-Chloro-phen-yl)-N-[(E)-4-(dimethyl-amino)-benzyl-idene]-1,3-thia-zol-2-amine | Acta crystallographica. Section E, Structure reports online |
21126022 | 20110113 | Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase | Journal of medicinal chemistry |
17442527 | 20070727 | Structural analysis of photo-degradation in thiazole-containing compounds by LC-MS/MS and NMR | Journal of pharmaceutical and biomedical analysis |
9696789 | 19980901 | Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex | Journal of virology |
Complexity: | 171 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 210.0018471 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 210.0018471 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 67.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Amines and Anilines
Oxazole/Thiazole
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS